Limited Time Offer of $99 Quell Classic Ending Soon! Shop Now
Articles
Share
PATCH (Woburn) 12/20/2018

State Lawmaker Tours Woburn Firm

From The Office of Cindy Friedman: On December 18, Senator Cindy F. Friedman (D-Arlington) visited the Woburn manufacturing facility NeuroMetrix, a company that develops wearable medical technology and point-of-care diagnostics to help patients and physicians better manage chronic pain, nerve disorders, and associated sleep disturbances. NeuroMetrix is the manufacturer of Quell, an FDA-approved, over-the-counter weareable therapeutic device for chronic pain.

Quell Wearable Pain Relief

Friedman met with Frank McGillin, Chief Commercial Officer, and Vanessa Thomas, Director of Consumer Marketing at NeuroMetrix to tour the facility, learn about Quell and its impact on treating those with chronic pain, and share her thoughts on policy issues related to chronic pain –particularly efforts to expand insurance coverage to include alternatives to opioid medications.

“I was excited to visit NeuroMetrix in Woburn and learn about the technology currently being manufactured to help treat chronic pain without a prescription,” said Friedman, co-chair of the Joint Committee on Mental Health, Substance Use and Recovery. “As we continue to address the over-prescription of opioids in our state, it is important that we look for additional ways for chronic pain patients to get the treatment that they need, and products like Quell are a viable and innovative alternative.”

Quell is a drug free solution that uses nerve stimulation to tap into the body’s natural pain response system to block chronic pain. It combines advanced neutrotechnology in a weareable format with an app for users to personalize and control therapy while tracking their pain and relevant health metrics.

The comprehensive opioid treatment bill that was championed by Friedman and enacted into law earlier this year ensures that patients with chronic pain have access to opioid and non-opioid treatment options that are vital for pain management. In addition, it continues to regulate the over-prescription of highly addictive opioids, which has traditionally been one of the major contributors of the opioid crisis.

READ MORE

Any Questions?

We're here for you.

Get in touch with us
or call 800.204.6577

Try Quell for yourself

It's risk free with our 60 day money back guarantee

Shop